Sept 17 (Reuters) - Liquidia Corp :
* LIQUIDIA CORP: UNITED THERAPEUTICS FILED NEW CROSS-CLAIMS IN FDA SUIT AGAINST FDA, RE-ASSERTING CHALLENGE TO FDA'S ACCEPTANCE OF CO'S YUTREPIA NDA
* LIQUIDIA- INTENDS TO DEFEND ITS ABILITY TO LAUNCH YUTREPIA & TO DEFEND ITSELF AGAINST UNITED'S ALLEGATIONS
Source text for Eikon: Further company coverage:
(Reuters.Briefs@thomsonreuters.com)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.